JAMA: Women have higher risk of death after ACS
Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS), but the difference appears attributable to factors such as severity and type of ACS, clinical differences and angiographic severity, according to a study in the August 26 issue of ournal of the American Medical Association.
“Although several studies have shown an improvement of prognosis in women over time, overall outcomes remain worse for women compared with men, providing a strong rationale for focusing on the study of sex-based differences in the outcome of ACS,” the authors wrote. Previous analyses of the differences in outcomes for men and women following ACS have reported conflicting results.
Jeffrey S. Berger, MD, of the New York University School of Medicine in New York City, and colleagues analyzed 136,247 patients pooled from a sample of 11 independent, international, randomized ACS clinical trials between 1993 and 2006 (28 percent women).
There were 102,004 patients (26 percent women) with STEMI; 14,466 with non-STEMI (29 percent women); and 19,777 with unstable angina (40 percent women). Women were older and had a higher prevalence of hypertension, hyperlipidemia, diabetes and heart failure. Men were more likely to be smokers and had a higher prevalence of prior MI and prior CABG.
The researchers found that women had a significantly higher unadjusted 30-day risk of death compared with men (9.6 vs. 5.3 percent). But after multivariable adjustment for clinical characteristics and clinical presentation, no significant difference was observed in 30-day mortality.
"Perhaps the most striking findings in our analyses relate to the examination of mortality according to type of ACS. We found a significant interaction between sex and type of ACS, such that 30-day mortality risk among women was modestly higher than men only for those patients presenting with STEMI," the authors wrote. “In patients with non-STEMI and unstable angina, women had a lower adjusted 30-day mortality risk than men. In fact, the strongest finding after full adjustment was lower risk among women with unstable angina."
The researchers also found that overall, women who underwent catheterization were more likely to have nonobstructive coronary artery disease and less likely to have multivessel disease compared with men. The relationship between sex and 30-day mortality was similar across the levels of angiographic disease severity.
"Our study suggests a better understanding of the observed sex-based differences. Sex-based differences exist in 30-day mortality among patients with ACS and vary depending on clinical presentation. However, these differences are markedly attenuated following adjustment for clinical differences and angiographic data. The attenuation in the difference in mortality suggests that much of the crude differences are explained by these factors. This study further highlights the clinical and angiographic differences among men and women at presentation with ACS. Understanding and considering these differences may lead to better risk stratification and treatment of all patients with ACS," Berger and colleagues concluded.
“Although several studies have shown an improvement of prognosis in women over time, overall outcomes remain worse for women compared with men, providing a strong rationale for focusing on the study of sex-based differences in the outcome of ACS,” the authors wrote. Previous analyses of the differences in outcomes for men and women following ACS have reported conflicting results.
Jeffrey S. Berger, MD, of the New York University School of Medicine in New York City, and colleagues analyzed 136,247 patients pooled from a sample of 11 independent, international, randomized ACS clinical trials between 1993 and 2006 (28 percent women).
There were 102,004 patients (26 percent women) with STEMI; 14,466 with non-STEMI (29 percent women); and 19,777 with unstable angina (40 percent women). Women were older and had a higher prevalence of hypertension, hyperlipidemia, diabetes and heart failure. Men were more likely to be smokers and had a higher prevalence of prior MI and prior CABG.
The researchers found that women had a significantly higher unadjusted 30-day risk of death compared with men (9.6 vs. 5.3 percent). But after multivariable adjustment for clinical characteristics and clinical presentation, no significant difference was observed in 30-day mortality.
"Perhaps the most striking findings in our analyses relate to the examination of mortality according to type of ACS. We found a significant interaction between sex and type of ACS, such that 30-day mortality risk among women was modestly higher than men only for those patients presenting with STEMI," the authors wrote. “In patients with non-STEMI and unstable angina, women had a lower adjusted 30-day mortality risk than men. In fact, the strongest finding after full adjustment was lower risk among women with unstable angina."
The researchers also found that overall, women who underwent catheterization were more likely to have nonobstructive coronary artery disease and less likely to have multivessel disease compared with men. The relationship between sex and 30-day mortality was similar across the levels of angiographic disease severity.
"Our study suggests a better understanding of the observed sex-based differences. Sex-based differences exist in 30-day mortality among patients with ACS and vary depending on clinical presentation. However, these differences are markedly attenuated following adjustment for clinical differences and angiographic data. The attenuation in the difference in mortality suggests that much of the crude differences are explained by these factors. This study further highlights the clinical and angiographic differences among men and women at presentation with ACS. Understanding and considering these differences may lead to better risk stratification and treatment of all patients with ACS," Berger and colleagues concluded.